US4654373A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Pharmaceutical formulations containing coenzyme Q10 suitable for topic administration
Assignee: Q-pharma Inc
•
Filing: 1985-03-12
•
Granted: 1987-03-31
•
Expires: 2005-03-12
Abstract
Abstract The present invention refers to new pharmaceutical compositions which contain Coenzyme Q 10 in amounts from 0.0001 to 10%, dissolved or suspended in a suitable vehicle and which are useful in the pharmaceutical and cosmethological field for the topical cutaneous treatment of skin diseases and for the prophylaxis of dystrophias or dysmetabolic conditions of the cutis.
Inventors
- 👤 Alberto Bertelli
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-05 02:10
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/045; A61K31/07; A61K31/12; A61K9/00; A61K9/0012; A61K9/0014; A61P; A61P17/00; A61K47/00; A61K47/06; A61K47/08; A61K47/10; A61K47/20; A61K47/22; A61K47/24; A61K47/26
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
44 words
A method of therapeutically treating impaired or damaged tissue in humans and animals which comprises topically administering to such tissue a composition comprising as the principal active ingredient a therapeutically effective amount of Coenzyme Q 10 (2,3-dimethoxy-5-methyl-6-decaprenyl-benzoquinone) in admixture with a pharmaceutically acceptable carrier.
Claim 2
Independent Claim
44 words
A method of therapeutically treating impaired or damaged tissue in humans and animals which comprises topically administering to such tissue a composition comprising as the principal active ingredient a therapeutically effective amount of Coenzyme Q 10 (2,3-dimethoxy-5-methyl-6-decaprenyl-benzoquinone) in admixture with a pharmaceutically acceptable carrier.
Claim 3
Dependent Claim
21 words
A method according to claim 1 in which the amount of Coenzyme Q 10 in said composition is 0.1%-10% by weight.
Claim 4
Dependent Claim
21 words
A method according to claim 1 in which the amount of Coenzyme Q 10 in said composition is 0.0001-0.1% by weight.
Claim 5
Dependent Claim
18 words
A method according to claim 1 in which the pharmaceutically acceptable carrier is olive, peanut or soybean oil.
Claim 6
Dependent Claim
23 words
A method according to claim 1 in which the composition is in the form of a paste, cream, ointment, gel, lotion or unguent.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1990-03-30 | 1990-09-29 | 1991-03-31 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1994-03-30 | 1994-09-29 | 1995-03-31 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1998-03-30 | 1998-09-29 | 1999-03-31 | $7700.00 | Window Closed / Lapsed |